ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 38 filers reported holding ESSA PHARMA INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,406,621 | +14.4% | 7,898,583 | 0.0% | 0.39% | +29.3% |
| Q2 2023 | $21,326,174 | -9.1% | 7,898,583 | 0.0% | 0.30% | -10.6% |
| Q1 2023 | $23,458,792 | +17.9% | 7,898,583 | 0.0% | 0.34% | +28.8% |
| Q4 2022 | $19,904,429 | +85.4% | 7,898,583 | +33.9% | 0.26% | +71.4% |
| Q3 2022 | $10,736,000 | -32.0% | 5,898,583 | +17.7% | 0.15% | -30.9% |
| Q2 2022 | $15,781,000 | -49.3% | 5,009,714 | -0.5% | 0.22% | -38.2% |
| Q1 2022 | $31,115,000 | -56.5% | 5,034,814 | 0.0% | 0.36% | -51.0% |
| Q4 2021 | $71,495,000 | +77.5% | 5,034,814 | 0.0% | 0.74% | +80.2% |
| Q3 2021 | $40,279,000 | -42.7% | 5,034,814 | +104.7% | 0.41% | -40.4% |
| Q2 2021 | $70,277,000 | +32.5% | 2,459,814 | +34.7% | 0.69% | +22.3% |
| Q1 2021 | $53,040,000 | – | 1,825,814 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |